Levita Hidayat

1.5k total citations · 1 hit paper
18 papers, 1.2k citations indexed

About

Levita Hidayat is a scholar working on Applied Microbiology and Biotechnology, Clinical Biochemistry and Infectious Diseases. According to data from OpenAlex, Levita Hidayat has authored 18 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Applied Microbiology and Biotechnology, 8 papers in Clinical Biochemistry and 4 papers in Infectious Diseases. Recurrent topics in Levita Hidayat's work include Antibiotic Use and Resistance (9 papers), Bacterial Identification and Susceptibility Testing (8 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). Levita Hidayat is often cited by papers focused on Antibiotic Use and Resistance (9 papers), Bacterial Identification and Susceptibility Testing (8 papers) and Antibiotics Pharmacokinetics and Efficacy (4 papers). Levita Hidayat collaborates with scholars based in United States and Sweden. Levita Hidayat's co-authors include Donald Hsu, Ryan Quist, Annie Wong‐Beringer, Kimberly Shriner, Janet Hindler, Åsa Karlsson, Michael Bolaris, Jason Yamaki, Esther Kim and C Andrew DeRyke and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, International Journal of Antimicrobial Agents and The Journal of Clinical Pharmacology.

In The Last Decade

Levita Hidayat

18 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High-Dose Vancomycin Therapy for Methicillin-Resistant Staphylococcus aureus Infections

2006 691 citations Levita Hidayat, Donald Hsu et al. Archives of Internal Medicine profile →

Peers

Levita Hidayat

PHARM

EPIDE

PHEOH

Donald Hsu United States

Jeffrey Graves United States

Kimberly Shriner United States

Nadia Z. Haque United States

Kenneth Klinker United States

Ryan P. Mynatt United States

Emi Minejima United States

Pamela A. Moise-Broder United States

William L. Musick United States

Sarah C J Jorgensen Canada

Donald Hsu United States

Levita Hidayat

868 ×1.2

579 ×1.0

352 ×1.2

PHARM

324 ×1.3

EPIDE

194 ×1.0

PHEOH

Citations per year, relative to Levita Hidayat Levita Hidayat (= 1×) peers Donald Hsu

Countries citing papers authored by Levita Hidayat

Since Specialization

Citations

This map shows the geographic impact of Levita Hidayat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Levita Hidayat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Levita Hidayat more than expected).

Fields of papers citing papers by Levita Hidayat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Levita Hidayat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Levita Hidayat. The network helps show where Levita Hidayat may publish in the future.

Co-authorship network of co-authors of Levita Hidayat

This figure shows the co-authorship network connecting the top 25 collaborators of Levita Hidayat. A scholar is included among the top collaborators of Levita Hidayat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Levita Hidayat. Levita Hidayat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Klinker, Kenneth, Levita Hidayat, Eric Wenzler, et al.. (2022). Use of Novel Antibiograms to Determine the Need for Earlier Susceptibility Testing and Administration for New β-Lactam/β-Lactamase Inhibitors in the United States. Antibiotics. 11(5). 660–660. 6 indexed citations

Klinker, Kenneth, Levita Hidayat, C Andrew DeRyke, Mary Motyl, & Karri A. Bauer. (2021). 151. Simplifying Empiric Antimicrobial Therapy Selection for Lower Respiratory Tract Infections in Intensive Care Unit Patients: Using Resistance Frequency to Guide Decision Making. Open Forum Infectious Diseases. 8(Supplement_1). S91–S91. 2 indexed citations

Hidayat, Levita, et al.. (2021). The antibiogram: key considerations for its development and utilization. JAC-Antimicrobial Resistance. 3(2). dlab060–dlab060. 60 indexed citations

Klinker, Kenneth, Levita Hidayat, C Andrew DeRyke, et al.. (2021). Antimicrobial stewardship and antibiograms: importance of moving beyond traditional antibiograms. Therapeutic Advances in Infectious Disease. 8. 1998246189–1998246189. 46 indexed citations

Bauer, Karri A., Levita Hidayat, Kenneth Klinker, Mary Motyl, & C Andrew DeRyke. (2021). 127. Living on the Edge: The Impact of MIC Distributions on Empiric Antibiotic Selection. Open Forum Infectious Diseases. 8(Supplement_1). S176–S177. 2 indexed citations

Klinker, Kenneth, Karri A. Bauer, C Andrew DeRyke, & Levita Hidayat. (2020). 103. Empiric Antibiotic Susceptibility Using a Traditional vs. Syndromic Antibiogram-Implications for Antimicrobial Stewardship Programs. Open Forum Infectious Diseases. 7(Supplement_1). S65–S66. 3 indexed citations

Hidayat, Levita, et al.. (2018). Use of an Anti-Infective Medication Review Process at Hospital Discharge to Identify Medication Errors and Optimize Therapy. Journal of Pharmacy Practice. 32(5). 488–492. 3 indexed citations

Venugopalan, Veena, et al.. (2016). Administration of a survey to evaluate the attitudes of house staff physicians towards antimicrobial resistance and the antimicrobial stewardship programme at a community teaching hospital. Journal of Global Antimicrobial Resistance. 4. 21–27. 24 indexed citations

Hidayat, Levita, et al.. (2016). Management of skin and soft-tissue infections at a community teaching hospital using a severity-of-illness tool. Journal of Antimicrobial Chemotherapy. 71(11). 3268–3275. 11 indexed citations

10.

Hidayat, Levita, et al.. (2016). Preparing Students to Enter the Race for Postgraduate Training. Journal of Pharmacy Practice. 30(4). 476–482. 9 indexed citations

11.

Huang, Vanthida, Michael E. Klepser, Paul O. Gubbins, et al.. (2015). Quantification of curricular content devoted to point-of- care testing for infectious diseases in schools and colleges of pharmacy in the United States. Pharmacy Education. 15(1). 1–6. 4 indexed citations

12.

Hidayat, Levita, et al.. (2012). Active-Learning Implementation in an Advanced Elective Course on Infectious Diseases. American Journal of Pharmaceutical Education. 76(5). 87–87. 28 indexed citations

13.

Hidayat, Levita, et al.. (2012). Pharmacy Student Absenteeism and Academic Performance. American Journal of Pharmaceutical Education. 76(1). 8–8. 50 indexed citations

14.

Beringer, Paul M., et al.. (2008). GFR estimates using cystatin C are superior to serum creatinine in adult patients with cystic fibrosis. Journal of Cystic Fibrosis. 8(1). 19–25. 32 indexed citations

15.

Beringer, Paul M., Xiyun Zhang, Levita Hidayat, et al.. (2008). Lack of Effect of P‐glycoprotein Inhibition on Renal Clearance of Dicloxacillin in Patients with Cystic Fibrosis. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(7). 883–894. 16 indexed citations

16.

Liu, Shanshan, Paul M. Beringer, Levita Hidayat, et al.. (2008). Probenecid, but Not Cystic Fibrosis, Alters the Total and Renal Clearance of Fexofenadine. The Journal of Clinical Pharmacology. 48(8). 957–965. 22 indexed citations

17.

Hsu, Donald, Levita Hidayat, Ryan Quist, et al.. (2008). Comparison of method-specific vancomycin minimum inhibitory concentration values and their predictability for treatment outcome of meticillin-resistant Staphylococcus aureus (MRSA) infections. International Journal of Antimicrobial Agents. 32(5). 378–385. 144 indexed citations

18.

Hidayat, Levita, Donald Hsu, Ryan Quist, Kimberly Shriner, & Annie Wong‐Beringer. (2006). High-Dose Vancomycin Therapy for Methicillin-Resistant Staphylococcus aureus Infections. Archives of Internal Medicine. 166(19). 2138–2138. 691 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact